Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Yano

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Anesthesiology|March 2, 2002
Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemiaRyosuke Nakayama, Toshiyuki Yano, Kazuo Ushijima, et al.
Basic Research in Cardiology|December 21, 2002
Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the ratYukinaga Nozawa, Tetsuji Miura, Takayuki Miki, et al.
Frontiers in Cardiovascular Medicine|May 30, 2023
Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overviewTatsuya Sato, Hidemichi Kouzu, Toshiyuki Yano, et al.
Circulation Research|February 22, 2014
Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signalingToshiyuki Yano, Marcella Ferlito, Angel Aponte, et al.
Cardiovascular Drugs and Therapy|February 12, 2022
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and MechanismsTetsuji Miura, Tatsuya Sato, Toshiyuki Yano, et al.
Cardiovascular Drugs and Therapy|October 19, 2010
Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPOTakahiro Sato, Masaya Tanno, Takayuki Miki, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 21, 2018
Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury?Toshiyuki Yano, Koki Abe, Masaya Tanno, et al.
International Journal of Molecular Sciences|July 29, 2023
mTOR Inhibitors Modulate the Physical Properties of 3D Spheroids Derived from H9c2 CellsMegumi Watanabe, Toshiyuki Yano, Tatsuya Sato, et al.
Journal of Anesthesia|August 4, 2004
A comparison of postoperative sore throat after use of laryngeal mask airway and tracheal tubeEtsuko Mizutamari, Toshiyuki Yano, Kazuo Ushijima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 22, 2007
Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43Tetsuji Miura, Toshiyuki Yano, Kazuyuki Naitoh, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Anesthesiology|March 2, 2002
Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemiaRyosuke Nakayama, Toshiyuki Yano, Kazuo Ushijima, et al.
Basic Research in Cardiology|December 21, 2002
Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the ratYukinaga Nozawa, Tetsuji Miura, Takayuki Miki, et al.
Frontiers in Cardiovascular Medicine|May 30, 2023
Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overviewTatsuya Sato, Hidemichi Kouzu, Toshiyuki Yano, et al.
Circulation Research|February 22, 2014
Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signalingToshiyuki Yano, Marcella Ferlito, Angel Aponte, et al.
Cardiovascular Drugs and Therapy|February 12, 2022
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and MechanismsTetsuji Miura, Tatsuya Sato, Toshiyuki Yano, et al.
Cardiovascular Drugs and Therapy|October 19, 2010
Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPOTakahiro Sato, Masaya Tanno, Takayuki Miki, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 21, 2018
Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury?Toshiyuki Yano, Koki Abe, Masaya Tanno, et al.
International Journal of Molecular Sciences|July 29, 2023
mTOR Inhibitors Modulate the Physical Properties of 3D Spheroids Derived from H9c2 CellsMegumi Watanabe, Toshiyuki Yano, Tatsuya Sato, et al.
Journal of Anesthesia|August 4, 2004
A comparison of postoperative sore throat after use of laryngeal mask airway and tracheal tubeEtsuko Mizutamari, Toshiyuki Yano, Kazuo Ushijima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 22, 2007
Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43Tetsuji Miura, Toshiyuki Yano, Kazuyuki Naitoh, et al.
Pageof 13